The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...

A new global study led by GlaxoSmithKline has found that a single dose of the RSV vaccine Arexvy (RSVPreF3 OA) offers strong ...

The ACIP has voted to recommend the use of respiratory syncytial virus (RSV) vaccines for adults aged 50 to 59.

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our infants with vaccination.

For instance, RSV vaccines are also recommended for pregnant people and infants. In this case, private insurance plans may cover the cost if you have one. These vaccines stimulate the immune ...